These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 3621179)

  • 1. Tumor cytotoxicity of polymorphonuclear leukocytes in beige mice: linkage of high responsiveness to linear beta-1,3-D-glucan with the beige gene.
    Fukase S; Inoue T; Arai S; Sendo F
    Cancer Res; 1987 Sep; 47(18):4842-7. PubMed ID: 3621179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen peroxide as a tumoricidal mediator of murine polymorphonuclear leukocytes induced by a linear beta-1,3-D-glucan and some other immunomodulators.
    Morikawa K; Kamegaya S; Yamazaki M; Mizuno D
    Cancer Res; 1985 Aug; 45(8):3482-6. PubMed ID: 2990672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of tumoricidal activity of polymorphonuclear leukocytes by a linear beta-1,3-D-glucan and other immunomodulators in murine cells.
    Morikawa K; Takeda R; Yamazaki M; Mizuno D
    Cancer Res; 1985 Apr; 45(4):1496-501. PubMed ID: 3156669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium-dependent and -independent tumoricidal activities of polymorphonuclear leukocytes induced by a linear beta-1,3-D-glucan and phorbol myristate acetate in mice.
    Morikawa K; Noguchi T; Yamazaki M; Mizuno D
    Cancer Res; 1986 Jan; 46(1):66-70. PubMed ID: 3079591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor activity of polymorphonuclear leukocytes activated by a beta-1,3-D-glucan.
    Kasai S; Fujimoto S; Nitta K; Baba H; Kunimoto T
    J Pharmacobiodyn; 1991 Sep; 14(9):519-25. PubMed ID: 1779406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic control of in vitro NK-activity and in vivo resistance to tumors.
    Kärre K; Klein GO; Kiessling R; Klein G
    Tokai J Exp Clin Med; 1983 Dec; 8(5-6):429-48. PubMed ID: 6681339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beta-glucan-binding lectin site of mouse CR3 (CD11b/CD18) and its function in generating a primed state of the receptor that mediates cytotoxic activation in response to iC3b-opsonized target cells.
    Xia Y; Vetvicka V; Yan J; Hanikýrová M; Mayadas T; Ross GD
    J Immunol; 1999 Feb; 162(4):2281-90. PubMed ID: 9973505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Listeriosis in beige mice and their heterozygous littermates.
    Cheers C; Wood P
    Immunology; 1984 Apr; 51(4):711-7. PubMed ID: 6706378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of polymorphonuclear leukocyte-mediated tumor cytotoxicity by serum factor(s).
    Araki A; Inoue T; Kimura S; Fukase S; Sendo F
    Jpn J Cancer Res; 1990 Jan; 81(1):69-78. PubMed ID: 2108949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
    Hong F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD
    Cancer Res; 2003 Dec; 63(24):9023-31. PubMed ID: 14695221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of cytotoxic polymorphonuclear leukocytes by in vivo administration of a streptococcal preparation, OK-432.
    Watabe S; Sendo F; Kimura S; Arai S
    J Natl Cancer Inst; 1984 Jun; 72(6):1365-70. PubMed ID: 6587156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxygen radical generation by polymorphonuclear leucocytes of beige mice.
    Kubo A; Sasada M; Nishimura T; Moriguchi T; Kakita T; Yamamoto K; Uchino H
    Clin Exp Immunol; 1987 Dec; 70(3):658-63. PubMed ID: 2830072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral (1-->3),(1-->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma.
    Cheung NK; Modak S
    Clin Cancer Res; 2002 May; 8(5):1217-23. PubMed ID: 12006541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium-independent induction of cytocidal activity of polymorphonuclear leukocytes by phorbol myristate acetate-like tumor promoters.
    Morikawa K; Sato T; Nakazawa H; Fujita M
    Life Sci; 1986 Mar; 38(12):1073-9. PubMed ID: 3083166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-glucan, a "specific" biologic response modifier that uses antibodies to target tumors for cytotoxic recognition by leukocyte complement receptor type 3 (CD11b/CD18).
    Yan J; Vetvicka V; Xia Y; Coxon A; Carroll MC; Mayadas TN; Ross GD
    J Immunol; 1999 Sep; 163(6):3045-52. PubMed ID: 10477568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early cellular responses in the peritoneal cavity of mice to antitumor immunomodulators.
    Morikawa K; Kikuchi Y; Abe S; Yamazaki M; Mizuno D
    Gan; 1984 Apr; 75(4):370-8. PubMed ID: 6735035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-glucan, immune function, and upper respiratory tract infections in athletes.
    Nieman DC; Henson DA; McMahon M; Wrieden JL; Davis JM; Murphy EA; Gross SJ; McAnulty LS; Dumke CL
    Med Sci Sports Exerc; 2008 Aug; 40(8):1463-71. PubMed ID: 18614945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positional cloning of the Chediak-Higashi syndrome gene: genetic mapping of the beige locus on mouse chromosome 13.
    Kingsmore SF; Barbosa MD; Tchernev VT; Detter JC; Lossie AC; Seldin MF; Holcombe RF
    J Investig Med; 1996 Oct; 44(8):454-61. PubMed ID: 8952226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-dependent cellular cytotoxicity mediated by polymorphonuclear leukocytes.
    Ikenami M; Mizuno D; Yamazaki M
    Jpn J Cancer Res; 1985 Jul; 76(7):637-43. PubMed ID: 3928561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab therapy of lymphoma is enhanced by orally administered (1-->3),(1-->4)-D-beta-glucan.
    Modak S; Koehne G; Vickers A; O'Reilly RJ; Cheung NK
    Leuk Res; 2005 Jun; 29(6):679-83. PubMed ID: 15863209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.